EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomics Profiling Reveals Pharmaceutical Excipient PEG400 Induces Nuclear-Receptor-Activation-Affected Lipid Metabolism and Metabolic Enzyme Expression

Mei Zhao iD, Siyuan Cao, Dan Yang, Leyuan Shang, Ye Hang, Pengjiao Wang, Shuo Zhang, Chaoji Li iD, Min Zhang, Xiuli Gao

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26041732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mei Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine & State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pha…. Hauptthemen laut MEDLINE: Lipid Metabolism, Proteomics, Polyethylene Glycols, Receptors, Cytoplasmic and Nuclear. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PEG400 is widely used as a pharmaceutical excipient in the biomedical field. Increasing evidence suggests that PEG400 is not an inert drug carrier; it can influence the activity of various drug-metabolizing enzymes and transporters, thereby affecting the in vivo process of drugs. It can also alleviate obesity and adipose tissue inflammation induced by a high-fat diet. In this study, we employed proteomics to investigate the impact of PEG400 on hepatic protein expression in rats. We found that over 40 metabolic enzymes were altered, with UDP-glucuronosyltransferase 1a9 (Ugt1a9) showing the most significant upregulation. This observation is consistent with our previous findings. KEGG pathway enrichment analysis revealed that PEG400 influences retinol metabolism, steroid hormone biosynthesis, drug metabolism, bile secretion, fatty acid degradation, peroxisome proliferator-activated receptor (PPAR) signaling pathway, and pentose and glucuronate interconversions. Western blot and molecular docking were used to quantitatively analyze related proteins. The results demonstrated that PEG400 promotes the metabolism of retinol to produce retinoic acid; enhances bile secretion by upregulating bile acid synthesis and transporter proteins; and activates the PPARα signaling pathway to regulate the expression of fat metabolism-related proteins, thereby reducing lipid accumulation. Furthermore, as natural ligands for nuclear receptors, retinoic acid and bile acids may activate nuclear receptors and initiate the regulation of target gene expression. We found upregulation of the nuclear receptors PPARα, retinoid X receptor alpha (RXRα), and pregnane X receptor (PXR). RXRα can form a dimer with PPARα or PXR to regulate the expression of target genes, which may explain the changes in the expression of numerous metabolic enzymes. This study provides a comprehensive understanding of the effects of PEG400 on liver metabolism in rats, reveals its potential biological functions, and offers new insights into the application and development of PEG400.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismProteomicsPolyethylene GlycolsReceptors, Cytoplasmic and NuclearExcipientsAnimalsRatsMaleLiverMolecular Docking SimulationRats, Sprague-DawleySignal TransductionGlucuronosyltransferasePPAR alpha

Stichwörter der Autor:innen

PEG400bile secretionmetabolic enzymesnuclear receptorproteomicretinol metabolism

Substanzen

Polyethylene GlycolsReceptors, Cytoplasmic and Nuclearpolyethylene glycol 400ExcipientsGlucuronosyltransferasePPAR alpha

Autor:innen und Institutionen

  • School of Basic Medicine & State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 561113, Chin…
  • Microbiology and Biochemical Pharmaceutical Engineering Center of Guizhou Provincial Department of Education, Guizhou Medical University, Guiyang 561113, China.
  • Experimental Animal Center, Guizhou Medical University, Guiyang 561113, China.

ORCID-Profile: Mei Zhao, Chaoji Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhao, M., Cao, S., Yang, D., Shang, L., Hang, Y., Wang, P., Zhang, S., Li, C., Zhang, M., & Gao, X. (2025). Proteomics Profiling Reveals Pharmaceutical Excipient PEG400 Induces Nuclear-Receptor-Activation-Affected Lipid Metabolism and Metabolic Enzyme Expression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041732

Vancouver

Zhao M, Cao S, Yang D, Shang L, Hang Y, Wang P, et al. Proteomics Profiling Reveals Pharmaceutical Excipient PEG400 Induces Nuclear-Receptor-Activation-Affected Lipid Metabolism and Metabolic Enzyme Expression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041732

BibTeX
@article{Zhao2025,
  author = {Zhao, Mei and Cao, Siyuan and Yang, Dan and Shang, Leyuan and Hang, Ye and Wang, Pengjiao and Zhang, Shuo and Li, Chaoji and Zhang, Min and Gao, Xiuli},
  title = {Proteomics Profiling Reveals Pharmaceutical Excipient PEG400 Induces Nuclear-Receptor-Activation-Affected Lipid Metabolism and Metabolic Enzyme Expression},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26041732}
}
Kostenlos starten →